November 28, 2024 - 06:05

Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
July 2, 2026 - 18:28
Building a scholarly communityA new initiative at the Massachusetts Institute of Technology is working to deepen connections between researchers across different disciplines. The SHASS Faculty Fellows Program, run by the MIT...
July 2, 2026 - 08:01
KPMG's AI Strategy Starts With Human Skills, Not TechnologyMany organizations are racing to deploy artificial intelligence, pouring billions into the latest models and infrastructure. But KPMG, one of the Big Four professional services firms, is taking a...
July 1, 2026 - 18:47
State funding kicks in for Minnesota counties to upgrade old technology systemsStarting July 1, Minnesota counties can begin overhauling the aging computer systems and online databases that power their daily operations. The state legislature approved $90 million this year...
July 1, 2026 - 12:50
BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion SystemBecton, Dickinson and Company, known as BD and traded under the ticker BDX, has secured a notable designation for its CentroVena One Insertion System. On June 23, the company announced that Vizient...